Cytokine storm and use of anakinra in a patient with COVID-19

被引：16
|
作者：
Nemchand, Priyanka [1 ]
Tahir, Hassan [2 ]
Mediwake, Rapti [3 ]
Lee, Jeffrey [1 ]
机构：
[1] Barnet Hosp, Royal Free London NHS Fdn Trust, Rheumatol & Gen Med, Barnet, North Ireland
[2] Barnet Hosp, Rheumatol & Gen Med, London, England
[3] Barnet Hosp, Royal Free London NHS Fdn Trust, Rheumatol, Barnet, North Ireland
来源：
BMJ CASE REPORTS | 2020年 / 13卷 / 09期
关键词：
infections; immunological products and vaccines; musculoskeletal and joint disorders; immunology; infectious diseases; INTERLEUKIN-1;
D O I：
10.1136/bcr-2020-237525
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
We present a case of a 50-year-old man with COVID-19 infection and acute respiratory distress syndrome as a result of a cytokine storm and use of anakinra, an interleukin 1-receptor antagonist that is normally used in the treatment of autoinflammatory disorders in adult patients. We saw a reduction in oxygen requirement and improvements in inflammatory markers and ferritin. Although we cannot determine its clinical efficacy from one case study, it may have a positive effect on the proinflammatory state that is associated with cytokine storm in COVID-19 infection.
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Rapid Response to Cytokine Storm Inhibition Using Anakinra in a Patient With COVID-19 Myocarditis
    Trpkov, Cvetan
    MacMullan, Paul
    Feuchter, Patricia
    Kachra, Rahim
    Heydari, Bobak
    Merchant, Naeem
    Bristow, Michael S.
    White, James A.
    CJC OPEN, 2021, 3 (02) : 210 - 213
  • [2] Early identification of COVID-19 cytokine storm and treatment with anakinra or tocilizumab
    Langer-Gould, Annette
    Smith, Jessica B.
    Gonzales, Edlin G.
    Castillo, Rhina D.
    Figueroa, Judith Garza
    Ramanathan, Anusha
    Li, Bonnie H.
    Gould, Michael K.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2020, 99 : 291 - 297
  • [3] The cytokine storm and COVID-19
    Hu, Biying
    Huang, Shaoying
    Yin, Lianghong
    JOURNAL OF MEDICAL VIROLOGY, 2021, 93 (01) : 250 - 256
  • [4] Covid-19 and Cytokine Storm
    Lopez Vergara, L.
    Torralba, L.
    De Diego, C.
    Lasierra, A.
    Lahoz, R.
    Abadia, C.
    Ruiz De Copegui, P.
    Godino, J.
    Cebollada, A.
    Jimeno, B.
    Bello, S.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [5] Proposed use of thalidomide for the cytokine storm of COVID-19
    Goihman-Yahr, Mauricio
    CLINICS IN DERMATOLOGY, 2020, 38 (04) : 508 - 508
  • [6] Covid-19 and leptospirosis: Cytokine storm and the use of steroids
    Ittyachen, Abraham M.
    TROPICAL DOCTOR, 2021, 51 (01) : 128 - 130
  • [7] Pericardial Cytokine “Storm” in a COVID-19 Patient: the Confirmation of a Hypothesis
    Cristian Deana
    Luigi Vetrugno
    Martina Fabris
    Francesco Curcio
    Emanuela Sozio
    Carlo Tascini
    Flavio Bassi
    Inflammation, 2022, 45 : 1 - 5
  • [8] Pericardial Cytokine "Storm" in a COVID-19 Patient: the Confirmation of a Hypothesis
    Deana, Cristian
    Vetrugno, Luigi
    Fabris, Martina
    Curcio, Francesco
    Sozio, Emanuela
    Tascini, Carlo
    Bassi, Flavio
    INFLAMMATION, 2022, 45 (01) : 1 - 5
  • [9] Calming the cytokine storm in COVID-19
    Randy Q. Cron
    Roberto Caricchio
    W. Winn Chatham
    Nature Medicine, 2021, 27 : 1674 - 1675
  • [10] Treatment of the Cytokine Storm in COVID-19
    Halacli, Burcin
    Topeli, Arzu
    JOURNAL OF CRITICAL & INTENSIVE CARE, 2020, 11 : 36 - 40
12345